Mativ (MATV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Feb, 2026Executive summary
Achieved year-over-year improvements in sales, Adjusted EBITDA, and margins for both Q4 and full year 2025, with organic sales growth of 2.5% and record free cash flow of $93.8 million, despite challenging macroeconomic and industry conditions.
Adjusted EBITDA increased 3% year-over-year to $224.7 million, with margin up 30 basis points to 11.3%.
Strategic focus on commercial excellence, balance sheet strengthening, and portfolio optimization, including facility closures, SKU rationalization, and a comprehensive portfolio review.
Transformation initiatives and disciplined execution fostered agility, speed, and accountability, positioning for sustainable, profitable growth.
Management highlighted disciplined execution, inventory management, and cost control as key drivers.
Financial highlights
Full year 2025 net sales were $1,987.0 million, up 2.5% organically year-over-year.
Adjusted EBITDA for 2025 was $224.7 million, up 3% versus prior year; Q4 Adjusted EBITDA grew 19% to $53.5 million.
Adjusted EPS increased to $0.70 from $0.62 year-over-year; GAAP net loss for FY25 was $337.4 million (GAAP EPS $(6.19)).
Free cash flow reached a record $93.8 million, up 139% year-over-year.
Net debt reduced by $61 million to $934 million; total liquidity at year-end was $515 million.
Outlook and guidance
Q1 2026 Adjusted EBITDA expected to increase 15%-20% year-over-year, despite soft demand and muted volume growth.
2026 capital expenditures planned at $45 million, split between growth and efficiency/safety projects.
Additional $15-$20 million in cost savings targeted for 2026; free cash flow expected to remain strong but slightly below 2025 due to growth investments.
Raw material cost headwinds of $20-$25 million anticipated, mainly in the second half of 2026.
Progress toward leverage target of 2.5-3.5x expected by year-end 2026.
Latest events from Mativ
- Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - SaaS/SAS growth and cost actions offset FAM headwinds, supporting 2025 profit improvement.MATV
Q4 202423 Dec 2025 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Board recommends voting FOR all proposals, with focus on governance, compensation, and ESG.MATV
Proxy Filing2 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025